Weight Loss Shot Greenlit for Heart Disease Patients

0:00On April 1st, big news from the UK's health bosses at NICE, their greenlighting the weight lost shot Sima Glutide, sold as Wagovi, for over 1 million folks battling heart disease. This weekly jab targets overweight and obese patients with specific heart and blood vessel issues aiming to slash their chances of heart attacks or strokes. It's already out there on the NHS for obesity and tied to diabetes under the name OZIMPIC, but now it's expanding to those with a body mass index of 27 or higher. Patients got a pair with stands, a calorie cut diet, and more movement for the full effect. Clinical trials, with 17,604 participants, showed a 20% drop in major heart events, and get this a kicked in. Before folks even shed pounds, hinting the drug hits the heart and vessels directly. NHS leaders are calling it life changing, especially for survivors of heart attacks or strokes facing their repeat risk.

1:00NIC crunched the numbers and deemed it cost effective, so expected rolling out within months. This can mean thousands dodging serious scares, giving people longer, stronger runs at life. It's another win where smarter meds meet real world, hustle.